Daily Stock Deals ‏@TOP10STOCKS 2m #URgent #UPdate! #SOLAR stocks Heating UP! $CSUN $LDK $STP Don't Miss double D gians! http://www.dailystockdeals.com/ #solarpower @TOP10STOCKS

Daily Stock Deals ‏@TOP10STOCKS 

#URgent #UPdate! #SOLAR stocks Heating UP! $CSUN $LDK $STP Don't Miss double D gians! http://www.dailystockdeals.com/  #solarpower @TOP10STOCKS

Hot Stock picks for 09/30/2013:ELON, ZLCS, GALE, Profit from our insight, daily stock deals and alerts!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Hot Stock picks for 09/27/2013: CXM, ZLCS, Profit from our insight, daily stock deals and alerts!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

$20,000 in just 5 months, on a thousand shares, MAKO made members rich! Deep insight, Real Results revealed!

You could have made a whopping $20,000 in just 5 month! if you had bought only a thousand shares! Deep insight, Real Results revealed! MAKO made our members rich!

See the original post here

http://www.oxbridgeresearch.com/penny-stock-alerts-hot-otc-stocks-penny-stock-blogs/584-mako-mako-surgical-trading-at-10-could-be-a-huge-winner-.html

MAKO, Mako Surgical, trading at $10, could be a huge winner

E-mail

Written by Administrator

Friday, 26 April 2013 10:24

MAKO Surgical (MAKO), a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific osteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment. In addition, the company offers MAKOplasty partial knee arthroplasty (PKA) products that enable resurfacing of one or two specific diseased compartments of the joint, preserving more soft tissue and healthy bone of the knee; and MAKOplasty Total Hip Arthroplasty, a surgical solution that enables orthopedic surgeons to perform total hip arthroplasty. Further, it provides RESTORIS onlay knee implant system for patients who lack tibia sclerotic bone beds; RESTORIS MCK unicompartmental and bicompartmental knee implant system to support the tissue and bone sparing goals of MAKOplasty PKA; and RESTORIS family of hip implant systems. The company markets and sells its products through direct sales force, as well as through independent orthopedic product agents and distributors. MAKO Surgical Corp. was founded in 2004 and is headquartered in Fort Lauderdale, Florida. Sources: company, OxBridge Research, Daily Stock Deals

Hot Energy Stock Picks for 09/26/2013: KIOR, AMCF, CERE, STEV, double digit gains, 2 days in a row! Profit from our insight, daily stock deals and alerts!

Hot Energy Stock Picks for 09/26/2013: KIOR, AMCF, CERE, STEV, double digit gains, 2 days in a row! Profit from our insight, daily stock deals and alerts!

Daily Stock Deals ‏@TOP10STOCKS 4m $STEV Double Digit Gains, 2 days in a row! find out more comprehensive Research Report http://oxbridgeresearch.com/docs/Stevia,STEV,Research%20Report.pdf … #hotstocks #hotpicks #stevia

Daily Stock Deals ‏@TOP10STOCKS 

$STEV Double Digit Gains, 2 days in a row! find out more comprehensive Research Report http://oxbridgeresearch.com/docs/Stevia,STEV,Research%20Report.pdf … #hotstocks #hotpicks #stevia

Daily Stock Deals ‏@TOP10STOCKS 3m Is it #REAL or #PHONY Money? #JPMorgan in Talks to Settle #Government Probes for $11 Billion #Reuters reported @TOP10picks #money #mortgage

Daily Stock Deals ‏@TOP10STOCKS 3m

Is it #REAL or #PHONY Money? #JPMorgan in Talks to Settle #Government Probes for $11 Billion #Reuters reported @TOP10picks #money #mortgage

Hot Stock picks for 09/25/2013: GLUU, ONTY, solar stocks,TSL, YGE, Get your daily stock picks FREE!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Our featured company: GNVC is relentless, Up 30%. Hot Stock picks for 09/24/2013: IKAN, ELON, IMRS, Get your daily stock picks FREE!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Big Gainers, Huge Winners 09/20/2013: RVP, CYCC, VRNM, get fresh picks, stock alerts daily for FREE!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

Get the Fresh, Piping Hot Picks Everyday! Sign-up, its FREE!

Hot Stock Picks for 09/19/2013: Shipping stocks cruising, FREE, DRYS, EGLE, our featured company VELT up double digits, check it out! Get your daily stock picks FREE!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Hot Penny Stock picks for 09/18/2013:IDN, PXLW, GERN, Get your daily stock picks FREE!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

China Pharma, CPHI, Profile, Summary

China Pharma| CPHI| Profile| Summary

China Pharma, CPHI, is a specialty pharmaceutical company that develops, manufactures and markets generic and brand pharmaceutical products for both western and traditional Chinese medicines in China. Currently, the company’s main focus for its therapeutics includes CNS, cardiovascular, cerebro-vascular, wound recovery, digestive disease, and infectious diseases. Its products are sold in 30 provinces, municipalities, and autonomous regions. The Company has 16 sales offices and approximately 680 proxy agents in the whole country.

China Pharma is located in the tax-free industrial zone of Haikou, Hainan Province, with manufacturing facility of 8,000 square meters. The Company is equipped with eight GMP(Good Manufacturing Practice) certified production lines and has the capacity to produce drugs in a variety of delivery mechanisms including freeze dried(lyophilized injectables), capsules, tablets, granules, injectables, and oral fluids(suspension). The company is positioning itself to benefit from China’s rapidly growing pharmaceutical market as it expands its product portfolio.

Research & Development

China Pharma develops generic products based on market demand by combining internal product development, strategic alliances with partners and collaborations of its products and businesses. The Company targets off-patent drugs with cumulative global sales over $1billion. Under Chinese law, China Pharma is able to obtain exclusivity protection for three or more years for new generics it brings to market. The disease areas China Pharma is currently focusing on are: neurology, hyperlipidemia and cardiovascular disease, hyperglycemia and diabetes , hypertension, and infectious diseases. China Pharma has built strong research and development partnerships with the following elite institutions in China and retains the ownership rights to all resulting intellectual property of products.

Modern Manufacturing Facilities

China Pharma has scalable GMP-certified manufacturing facilities with eight different modern production lines. These facilities passed the GMP-certification when it was first introduced in 2003 and passed the latest round in 2008. The GMP-certification is repeated every five years.

In 2008 the Company invested $3.0 million to increase capacity of the dry powder line. China Pharma’s cutting edge production lines can manufacture products in the following forms of delivery: tablets; capsules; injectables; granules; oral fluids (suspension); and freeze dried (lyophilized injectables). Its production capacity fully satisfies the needs of the current portfolio.

→ -The company received GMP certification in 2003
→ - Recognized as “The Best Enterprise for Storing SARS Medicine” by Hainan Food and Drug Administration.

→ -Received national key new products certificate for Buflomedil Hydrochloride by the State Science and Technology Department, State Taxation Bureau, Ministry of Commerce, State Bureau of Quality Supervision, Inspection and Quarantine, and State Environmental Protection Bureau.

→ -Designated as key technology project in Hainan for Buflomedil Hydrochloride by

Haikou Municipality.

Source: China Pharma, OxBridge Research, Daily Stock Deals, OTC King, PSM

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Disclosure/Disclaimer:- OxBridge Research publishes sponsored research reports, advertorials and corporate profiles on its portal and several other websites/blogs, including this website/blog, owned and operated by OxBridge and/or its affiliates. OxBridge Research is not a Broker Dealer or a Registered Financial Adviser in any jurisdiction, whatsoever. All the information published on its website(s) and/or distributed to its members via various electronic means is for general awareness and entertainment purpose only. OxBridge urges investors to do their own due diligence and consult with their financial adviser prior to making any investment decision. We are expecting a payment from the company/a third party/shareholder. We receive compensation from companies for providing various IR services, including publication, advertisement,and social media awareness, therefore our views/opinion are inherently biased. Please read the full disclosure/disclaimer, if you need assistance contact Editor@OxBridgeResearch.com

OxbridgeResearch.com, All Rights Reserved. Trademarks/logos are of their respective owners.

It's YOUR money - Invest WISELY _TM

AXN,Aoxing Pharmaceuticals,Profile,Summary

AXN| Aoxing Pharmaceuticals | Profile | Summary

Aoxing Pharmaceuticals (AXN) is a specialty pharmaceutical company engaged in research, development, manufacturing and distribution of a variety of narcotics and pain-management products.

Aoxing was Founded in 1655, more than 300 years of heritage and deep roots in traditional and contemporary Chinese medicine.

The company has China's largest research & development facility (over 300 acre campus) and most advanced manufacturing facility for highly regulated narcotic medicines. Over 500 employees are dedicated in research and development of drugs for pain management, neurological disorders and narcotics.

Its facility is one of the few GMP facilities licensed for the manufacture of highly regulated narcotic medicines by the China State Food and Drug Administration (SFDA). It has strategic alliance partnerships with global pharmaceutical companies like the UK's Johnson Matthey Plc (LSE: JMAT), QRx Pharma (ASX: QRX) of Australia and others. Aoxing is based in China and its US office is located in Jersey City, NJ.

Source: Aoxing Pharmaceuticals, OxBridge Research, Daily Stock Deals, OTC King. PSM

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Disclosure/Disclaimer:- OxBridge Research publishes sponsored research reports, advertorials and corporate profiles on its portal and several other websites/blogs, including this website/blog, owned and operated by OxBridge and/or its affiliates. OxBridge Research is not a Broker Dealer or a Registered Financial Adviser in any jurisdiction, whatsoever. All the information published on its website(s) and/or distributed to its members via various electronic means is for general awareness and entertainment purpose only. OxBridge urges investors to do their own due diligence and consult with their financial adviser prior to making any investment decision. We are expecting a payment from the company/a third party/shareholder. We receive compensation from companies for providing various IR services, including publication, advertisement,and social media awareness, therefore our views/opinion are inherently biased. Please read the full disclosure/disclaimer, if you need assistance contact Editor@OxBridgeResearch.com

OxbridgeResearch.com, All Rights Reserved. Trademarks/logos are of their respective owners.

It's YOUR money - Invest WISELY _TM

Hot Penny Stock picks for 09/13/2013: AXN, CTIC, GNVC, Get your daily stock picks FREE!

Daily Stock Deals ‏@TOP10STOCKS Holy Cow! look $GNVC you do the math! we profiled and alerted on 09/06 http://www.dailystockdeals.com/  #hot #picks @top10picks #alert @TOP10STOCKS

Hot Stock Picks: EXTR, MARK, TBOW check our profile company $GNVC up 30% want more? Get your daily stock picks FREE!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Daily Stock Deals ‏@TOP10STOCKS 9m Did you make 40% today? you could've: $STEV up 7% $VTUS up 15% $GTXI up 21%, Total: 43% update http://www.dailystockdeals.com/ #hotpicks #hotalerts Retweeted by PENNYstockMONSTER

1. Daily Stock Deals ‏@TOP10STOCKS 8m

   Did you make 40% today? you could've: $STEV up 7% $VTUS up 15% $GTXI up 21%, Total: 43% update http://www.dailystockdeals.com/  #hotpicks #hotalerts

   Retweeted by PENNYstockMONSTER

Hot Penny Stock picks for 09/11/2013: VTUS, STEV, GTXI, Get your daily stock picks FREE!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

Get the Fresh, Piping Hot Picks Everyday! Sign-up, its FREE!

STEV, Stevia, could rebound, see the press release

 

Stevia Corp. President Discusses Expansion Plans.

Blankenbaker Delivers First in Series of 3 Articles Detailing New Revenue Streams

INDIANAPOLIS, IN--(Marketwired - Sep 10, 2013) -  Stevia Corp. (OTCQB: STEV) ("Stevia Corp." or the "Company"), a farm management company focused on the economic development of stevia, the fastest growing product in the alternative sweetener sector, is pleased to offer insights regarding key aspects of its planned expansion plans.
Stevia Corp. successfully completed the first phase of its commercialization program achieving its targeted $3million revenue over the six month period ended June 30, 2013. The company is now focused on expanding its proven business model and aims to double production by the spring of 2014.
George Blankenbaker, Stevia Corp. President, comments, "Following Stevia Corp's successful harvest during the spring of 2013, our project was featured in the Vietnam Journal of Finance and a 1/2 hour nationally televised program. This recognition provided additional credibility and we are now being approached by international companies to grow for them as well as discussing potential joint ventures to operate processing factories in Vietnam. We have completed test shipments to both South Korea and Europe proving that we can meet international standards and we are preparing to enter into long-term supply agreements with buyers from both South Korea and the Netherlands."
Mr. Blankenbaker further explains, "Because Stevia Corp's model has proven to be a win-win for all parties and the farmers who participated earned higher revenues, we have the full support of the Vietnamese government and there is a waiting list of farmers who want to participate in our program. This enables us to select the best operators and maintain our high quality control standards as we expand. These key factors provide the foundation and impetus for us to rapidly expand our production to meet the growing demands of international buyers."
Blankenbaker concludes, "To successfully operate in a new market, it generally takes a few years for a company to establish itself and become well entrenched in the region while garnering the confidence and support of all parties, including the local farm communities as well as the local and national governments. But once achieved, it creates a strong foundation for rapid development. Stevia Corp has now attained this milestone and is preparing for the next phase of rapid expansion."
Further details of the Company's business, finances, appointments and agreements can be found as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information visit: www.steviacorp.us.
Disclosure/Disclaimer: Stevia is a client and we have been compensated by the company and/or a third party for research/marketing/advertising services. Please read the full disclosure. Thanks

Hot Penny Stock picks for 09/10/2013: INO, ZHNE, CYCC, Get your daily stock picks FREE!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Hot Penny Stock picks for 09/09/2013: ONCY, CUR, PPHM, RVLT, Get your daily stock picks FREE!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

GenVec, GNVC, Profile, Summary

GenVec | GNVC | Profile | Summary

GenVec, (GNVC) is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. A key component of the company's strategy is to develop and commercialize products through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns.

GenVec’s development programs address therapeutic areas such as hearing loss, balance disorders, and cancer; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus type 2 (HSV-2), dengue fever, influenza, malaria, and human immunodeficiency virus (HIV).

The GenVec's Advantage

The company's core technology has the important advantage of localizing protein delivery in the body. This is accomplished by using adenovector platform to locally deliver genes to cells, which then direct production of the desired protein. This approach reduces side effects typically associated with systemic delivery of proteins. For vaccines, the goal is to induce an immune response against a target protein or antigen. This is accomplished by using an adenovector to deliver a gene that causes production of an antigen, which then stimulates the desired immune reaction by the body.

GenVec’s novel proprietary adenovectors

‒

No pre existing immune recognition

‒

Built on rare human and nonhuman adenovirus serotypes

‒

New GC technology shows superior performance for genetic vaccines

‒

Multiple capsid modified vectors -AdH technology

‒

Multiple genes/multiple antigens

‒

Targeted and specific delivery Proprietary adenovectors and cell lines

‒

Novel proprietary non replicating adenovirus vectors

•

Very low sero -prevalence in humans

•

Outstanding gene/antigen delivery properties

‒

Cell line master banks and master file with FDA

Hearing Restoration Molecular Therapeutic

•

Dengue Virus Genetic Vaccine

•

Foot and Mouth Virus Genetic Vaccine

•

Malaria Genetic Vaccine

•

RSV Genetic Vaccine

•

HSV Molecular Therapeutic and Genetic Vaccine

A platform of adenovirus vectors built to meet product needs for molecular therapeutics and genetic vaccines

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Disclosure/Disclaimer:- OxBridge Research publishes sponsored research reports, advertorials and corporate profiles on its portal and several other websites/blogs, including this website/blog, owned and operated by OxBridge and/or its affiliates. OxBridge Research is not a Broker Dealer or a Registered Financial Adviser in any jurisdiction, whatsoever. All the information published on its website(s) and/or distributed to its members via various electronic means is for general awareness and entertainment purpose only. OxBridge urges investors to do their own due diligence and consult with their financial adviser prior to making any investment decision. We are expecting a payment from the company/a third party/shareholder. We receive compensation from companies for providing various IR services, including publication, advertisement,and social media awareness, therefore our views/opinion are inherently biased. Please read the full disclosure/disclaimer, if you need assistance contact Editor@OxBridgeResearch.com

OxbridgeResearch.com, All Rights Reserved. Trademarks/logos are of their respective owners.

It's YOUR money - Invest WISELY _TM

Stock picks for 09/05/2013: FCEL, PLUG, ENVI, LOCM, Get your daily stock picks FREE!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Stock picks for 09/04/2013: AVNW,INO, LEDS,Get your daily stock picks FREE! $GNVC up a whopping 99%

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.

Stock picks for 09/03/2013: IBIO, HSOL, ZLCS, Get your daily stock picks FREE!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.